HemaCare Corp (HEMA):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:HemaCare Corp (HEMA) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7475
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
HemaCare Corp (HemaCare) is a provider of biological blood products and services. The company offers primary blood cells and tissues derived from normal and mobilized peripheral blood, cord blood, and bone marrow. It spans its expertise in isolations, custom cell collections and testing of primary cells for research use. HemaCare offers apheresis collection services to industry and academic organizations for clinical trials from phase I through phase III preclinical research and clinical cell therapy applications. The company also provides SOP development services, consulting services in personnel training, and quality and regulatory compliance, among others. HemaCare is headquartered in Los Angeles, California, the US.

HemaCare Corp (HEMA) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
HemaCare Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
HemaCare Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
HemaCare Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
HemaCare Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
HemaCare Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
HemaCare Corp, Medical Equipment, Deal Details 10
Equity Offering 10
HemaCare to Raise USD1.2 Million in Second Tranche of Private Placement of Shares 10
HemaCare Raises USD2.5 Million in First Tranche of Private Placement of Shares 11
Acquisition 12
New York Blood Center Acquires Coral Blood Services From HemaCare 12
HemaCare Corp – Key Competitors 13
HemaCare Corp – Key Employees 14
HemaCare Corp – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Strategy And Business Planning 16
Sep 04, 2018: HemaCare details expanded GMP capabilities at CAR-TCR Summit in Boston, MA 16
Jul 24, 2017: HemaCare Signs Long Term Lease for Facility Relocation and Expansion 17
Financial Announcements 18
Mar 08, 2018: HemaCare Reports Full Year 2017 Results 18
Aug 21, 2017: HemaCare Reports Strong First Half 2017 Results 19
Mar 13, 2017: HemaCare Reports Strong, Profitable 2016 Results 20
Corporate Communications 21
Jul 17, 2018: HemaCare expands development of cellular therapy services by bolstering scientific team with two strategic new hires 21
Jul 24, 2017: HemaCare Signs Long Term Lease for Facility Relocation and Expansion 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
HemaCare Corp, Medical Equipment, Key Facts, 2017 2
HemaCare Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
HemaCare Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
HemaCare Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
HemaCare Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
HemaCare Corp, Deals By Market, 2012 to YTD 2018 8
HemaCare Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
HemaCare to Raise USD1.2 Million in Second Tranche of Private Placement of Shares 10
HemaCare Raises USD2.5 Million in First Tranche of Private Placement of Shares 11
New York Blood Center Acquires Coral Blood Services From HemaCare 12
HemaCare Corp, Key Competitors 13
HemaCare Corp, Key Employees 14

List of Figures
HemaCare Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
HemaCare Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
HemaCare Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
HemaCare Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
HemaCare Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
HemaCare Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
HemaCare Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
HemaCare Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[HemaCare Corp (HEMA):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Andalay Solar Inc (WEST):企業の財務・戦略的SWOT分析
    Andalay Solar Inc (WEST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • NovoCure Ltd (NVCR):企業の財務・戦略的SWOT分析
    NovoCure Ltd (NVCR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • United-Guardian Inc (UG):企業の財務・戦略的SWOT分析
    Summary United-Guardian Inc (United-Guardian) is a diversified company that manufactures and markets healthcare products. The company offers pharmaceuticals, cosmetic ingredients, health care products and proprietary industrial products, among others. It provides medical devices such as lubrajel flu …
  • Endeavor Energy Resources LP:石油・ガス:M&Aディール及び事業提携情報
    Summary Endeavor Energy Resources LP (Endeavor Energy) is an independent oil and gas company that acquires, explores, develops and produces crude oil and natural gas properties. The company has operations in the Delaware Basin which offers horizontal and vertical drilling in Winkler, Ward, Loving, R …
  • DHL Supply Chain (formerly Exel Inc.):戦略・SWOT・企業財務分析
    DHL Supply Chain (formerly Exel Inc.) - Strategy, SWOT and Corporate Finance Report Summary DHL Supply Chain (formerly Exel Inc.) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Oncolytics Biotech Inc (ONC)-製薬・医療分野:企業M&A・提携分析
    Summary Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company’s lead product, Reolysin, a formulation of the human reovirus, is at Phase II clinical trials indi …
  • Proximus SA (formerly Belgacom SA):戦略・SWOT・企業財務分析
    Proximus SA (formerly Belgacom SA) - Strategy, SWOT and Corporate Finance Report Summary Proximus SA (formerly Belgacom SA) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Konica Minolta Inc (4902):医療機器:M&Aディール及び事業提携情報
    Summary Konica Minolta, Inc. (Konica Minolta) develops, manufactures and sells printing systems and solutions for production print professionals. The company’s product portfolio includes multi-functional peripherals (MFPs), printers, equipment for production print systems and graphic arts, equipment …
  • NovioSense BV-医療機器分野:企業M&A・提携分析
    Summary NovioSense BV (NovioSense) is a medical device company that develops a wireless technology platform for non-invasive monitoring of disease biomarkers. The company provides NovioSense, a glucose sensor to continuously monitor glucose levels in the tear fluid and sends a wireless signal to a h …
  • Geberit AG:戦略・SWOT・企業財務分析
    Geberit AG - Strategy, SWOT and Corporate Finance Report Summary Geberit AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Alcoa Inc:戦略・SWOT・企業財務分析
    Alcoa Inc - Strategy, SWOT and Corporate Finance Report Summary Alcoa Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Prospect Medical Holdings Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Prospect Medical Holdings Inc (PMHI) is a healthcare service provider that offers patient care services. The center offers medical, surgical and psychiatric services, among others. It owns and operates hospitals, clinics and physician networks that offers managed care services for HMO enrole …
  • QAD Inc (QADA):企業の財務・戦略的SWOT分析
    QAD Inc (QADA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Amsted Industries Inc:企業の戦略・SWOT・財務情報
    Amsted Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Amsted Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Neuren Pharmaceuticals Ltd (NEU):企業の財務・戦略的SWOT分析
    Summary Neuren Pharmaceuticals Ltd (Neuren Pharma) is a biopharmaceutical company that develops drugs for brain injury, neurodevelopmental and neurodegenerative disorders. The company provides pipeline products such as trofinetide and NNZ-2591. Its trofinetide has a pharmacokinetic profile, which is …
  • Allegra Orthopaedics Ltd (AMT):企業の財務・戦略的SWOT分析
    Allegra Orthopaedics Ltd (AMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • NicOx SA (COX):企業の財務・戦略的SWOT分析
    Summary Nicox SA is an ophthalmology company developing solutions to help maintain vision and improve ocular health. The company is engaged in the research, development and marketing investigational drugs for ophthalmological diseases. The aims to produce therapeutic products which aims to address t …
  • Verizon Communications Inc (VZ):企業の財務・戦略的SWOT分析
    Verizon Communications Inc (VZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • H. Lundbeck A/S:企業の戦略・SWOT・財務情報
    H. Lundbeck A/S - Strategy, SWOT and Corporate Finance Report Summary H. Lundbeck A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Tri-County Rural Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Tri-County Rural Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆